(1947), a 1:400,000 dilution of subtilin (2.5 jug per ml) regularly inhibited the growth of Mycobacterium tuberculosis for 12 days. To study the bactericidal effect, they inoculated 1 ml of each dilution not showing visible growth into each of two guinea pigs. The animals receiving material from tubes containing 1: 20,000 and 1: 10,000 dilutions of subtilin did not develop tuberculosis. These workers also found that subtilin inhibited tubercle formation in the allantoic membrane of the chick embryo, but they could demonstrate no effect on tuberculous infection of rabbit corneas by topical application of the drug, or on tuberculous infection in hamsters by subcutaneous injections of subtilin for 6 weeks. Knight and Tompsett (1948) observed that subtilin was effective in inhibiting the growth of tubercle bacilli only when the organisms were growing in a dispersed fashion, as in media containing wetting agents such as sorbitan monooleate. In media not containing wetting agents, where the bacilli were growing in aggregates, subtilin did not inhibit their growth. They reported that the course of tuberculous infection in mice was not affected by much larger daily doses of subtilin than those necessary for protection against pneumococcus or streptococcus infection. Farber et al. (1948) reported the sensitivity to subtilin of 6 strains of tubercle bacilli recently isolated from patients. Three were sensitive to 1:400,000, two were sensitive to 1:200,000, and one to 1:100,000 dilution of the drug. Presumably these tests were done in sorbitan monooleate albumin medium.
This report describes experiments designed to clarify the status of subtilin as a tuberculostatic agent in the test tube and in guinea pigs.
In vitro results. riched media (sorbitan monooleate albmin and P and B with beef serum), 0.1 ml of the culture (about 0.03 mg, dry wt) was inoculated into each tube; twice this amount was used for the two synthetic media.
The results of these tests are presented in table 1. In the three media containing no sorbitan monooleate, in which the growth was granular, subtilin had very little inhibitory effect, even in concentrations of 100 or more ,ug per ml (5.5 units per ml). In the sorbitan monooleate albumin medilm, in which the growth was dispersed, 10 pug per ml inhibited growth for about 12 days, but then progresive turbidity appeared. One hundred ug per ml prevented growth for 27 days. 
DISCUSION
The results herein described show that subtilin has only a very slight inhibitory effect on the growth of the H37Rv strain of the tubercle bacillus in fluid media without a dispersing agent. In the presence of sorbitan monooleate, which produces a dispersed growth, the drug is moderately effective. This confirms the observations of Knight and Tompsett (1948) . Anderson and Wong (1946 ), Wong et al. (1947 ), and Farber et al. (1948 define the minimal inhibitory concentration of subtilin for Mycobacterium tuberculo8is as approximately 2.5 to 5.0 pug per ml in sorbitan monooleate albumin medium. The observation period was limited to 21 days because subtilin is not stable in neutral solutions, losing 68 per cent of its activity at 37 C at pH 7.3 in 6 days, and 57 per cent at pH 6.8 in 6 days (Dimick, Alderton, Lewis, Lightbody, and Fevold, 1947) . In the tests reported here, growth in 10 ,g of subtilin per ml was beginning to appear at about the twelfth day. Contributing to the greater inhibitory effect found by Anderson and his group is the fact that the medium they used contained 0.05 per cent sorbitan monooleate, 0.15 per cent albumin, and no glucose, whereas in this laboratory the formula contains less sorbitan monooleate (0.02 per cent), more albumin (0.5 per cent), and 0.2 per cent glucose. In addition, there is as yet no standard subtilin preparation, and it is therefore difficult to compare results obtained with different preparations.
Subtilin produced no significant effect on the tuberculosis of the guinea pigs included in this experiment. The dosage used was close to the maximal tolerated dose for prolonged therapy with this preparation. Progressive loss of weight was produced by 4.0 mg (220 units) per day, and it was deemed inadvisable to increase the dose further. The same negative results have been obtained with mice (Knight and Tompsett, 1948) and with hamsters (Anderson and Wong, 1946 absorbed slowly. In rabbits, up to 100 mg per kg injected intramuscularly produced blood levels of no more than 2 parts per million (Wilson, Lewis, and Humphreys, 1948) . This insolubility in physiological fluids undoubtedly contributes to the poor results obtained. Other infections, however, such as pneumococcus, streptococcus, and anthrax, havebeen reported to respond very well to parenteral treatment with subtilin in guiea pigs and mice (Salle and Jann, 1946a,b,c) .
SUMMRY
Subtilin had a moderate inhibitory effect on the growth of the H37Rv strain of the tubercle bacillus in sorbitan monooleate albumin liquid medium, but very little effect in the other three media that did not contain sorbitan monooleate.
Subtilin did not influence the course of a tuberculous infection in guinea pigs produced by the H37Rv strain of the tubercle bacillus.
